These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 2395828

  • 21. Successful pregnancies in patients with hyperprolactinemia--clinical and endocrinological studies on mothers and babies.
    Goto T, Narita O, Suganuma N, Suzuki M, Tomoda Y, Kuwayama A, Kageyama N.
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Apr; 35(4):550-8. PubMed ID: 6854101
    [Abstract] [Full Text] [Related]

  • 22. The efficacy, tolerability and safety of Parlodel LAR versus Parlodel in hyperprolactinemia.
    Bolanowski M, Milewicz A, Bohdanowicz-Pawlak A, Bednarek-Tupikowska G, Jedrzejak JA, Lancranjan I.
    Endokrynol Pol; 1993 Apr; 44(4):467-76. PubMed ID: 8055815
    [Abstract] [Full Text] [Related]

  • 23. Prolactin secretion in the empty sella syndrome, in prolactinomas and in acromegaly.
    Brismar K.
    Acta Med Scand; 1981 Apr; 209(5):397-405. PubMed ID: 6787839
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. New perspectives in medical management of hyperprolactinemia.
    Montini M, Gianola D, Pagani MD, Tengattini F, Dominoni P, Sileo F, Ferrari L, Stroppa S, Gualteroni L, Pagani G.
    Endocrinol Exp; 1990 Mar; 24(1-2):159-66. PubMed ID: 2361458
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Medical treatment of hyperprolactinemia.
    Fossati P, Dewailly D, Thomas-Desrousseaux P, Buvat J, Fermon C, Lemaire A, Bourdelle-Hego MF, Pouyol-Motte H, Lemaitre G, Clarisse J.
    Horm Res; 1985 Mar; 22(3):228-38. PubMed ID: 4054843
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: prevalence, clinical definition, and therapeutic strategy.
    Di Sarno A, Landi ML, Cappabianca P, Di Salle F, Rossi FW, Pivonello R, Di Somma C, Faggiano A, Lombardi G, Colao A.
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5256-61. PubMed ID: 11701688
    [Abstract] [Full Text] [Related]

  • 32. Hyperprolactinaemia and pituitary adenomas in adolescence.
    Dissaneevate P, Warne GL.
    J Pediatr Endocrinol Metab; 1998 Nov; 11(4):531-41. PubMed ID: 9777574
    [Abstract] [Full Text] [Related]

  • 33. [Clinical course and the effectiveness of conservative treatment of prolactin-secreting pituitary adenoma].
    Sabakhtarashvili MA, Veĭnberg EG, Kurashvili RB, Kanchaveli ZSh.
    Akush Ginekol (Mosk); 1989 Oct; (10):50-4. PubMed ID: 2618957
    [Abstract] [Full Text] [Related]

  • 34. Comparison between a slow-release oral preparation of bromocriptine and regular bromocriptine in patients with hyperprolactinemia: a double blind, double dummy study.
    Moro M, Maraschini C, Toja P, Masala A, Alagna S, Rovasio PP, Ginanni A, Lancranjan I, Cavagnini F.
    Horm Res; 1991 Oct; 35(3-4):137-41. PubMed ID: 1806467
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Further acquisitions on gonadal function in bromocriptine treated hyperprolactinemic male patients.
    Zini D, Carani C, Baldini A, Cavicchioli C, Piccinini D, Marrama P.
    Pharmacol Res Commun; 1986 Jul; 18(7):601-9. PubMed ID: 3532137
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.